enGene Therapeutics Inc.
ENGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001980845
In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.
Other share classesENGNW
13F holders, Q3 2024
Institutional positions in enGene Therapeutics Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- 0 vs. Q2 2024
- Shares held
- 34.3M
- +1.68M (+5.2%) vs. Q2 2024
- Total value
- $227.7M
- −$79.4M (−25.9%) vs. Q2 2024
- New holders
- 6
- 10 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $86.5M |
| Q1 2026 | 62 | $383.0M |
| Q4 2025 | 58 | $530.8M |
| Q3 2025 | 37 | $279.1M |
| Q2 2025 | 36 | $147.1M |
| Q1 2025 | 31 | $183.4M |
| Q4 2024 | 34 | $274.7M |
| Q3 2024 | 30 | $227.7M |
| Q2 2024 | 30 | $307.1M |
| Q1 2024 | 31 | $536.1M |
| Q4 2023 | 11 | $130.9M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding enGene Therapeutics Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FCPM III Services B.V. | 8,677,951 | $57.3M | 9.84% | 00.0% | Unchanged |
| VR Adviser, LLC | 3,565,841 | $23.5M | 1.23% | +739,858+26.2% | Added |
| Blue Owl Capital Holdings LP | 3,058,969 | $20.2M | 3.91% | +609,142+24.9% | Added |
| Deep Track Capital, LP | 2,607,633 | $17.2M | 0.55% | +357,633+15.9% | Added |
| Adage Capital Partners GP, L.L.C. | 2,329,768 | $15.4M | 0.03% | −970,232−29.4% | Reduced |
| BVF Inc | 2,251,037 | $14.9M | 0.43% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 1,736,227 | $11.5M | 0.89% | +1,736,227 | New |
| Franklin Resources Inc | 1,189,952 | $9.19M | 0.00% | +389,918+48.7% | Added |
| Omega Fund Management, LLC | 1,076,357 | $7.10M | 4.44% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 1,000,000 | $6.63M | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,000,000 | $6.60M | 0.35% | 00.0% | Unchanged |
| Logos Global Management LP | 800,000 | $5.28M | 0.59% | −400,000−33.3% | Reduced |
| Soleus Capital Management, L.P. | 800,000 | $5.28M | 0.44% | 00.0% | Unchanged |
| Sr One Capital Management, LP | 747,750 | $4.94M | 0.99% | +247,750+49.6% | Added |
| Boxer Capital, LLC | 727,900 | $4.80M | 0.24% | 00.0% | Unchanged |
| Marshall Wace, LLP | 681,545 | $4.50M | 0.01% | −83,100−10.9% | Reduced |
| Vivo Capital, LLC | 678,705 | $4.48M | 0.37% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 663,000 | $4.38M | 0.02% | +619,100+1,410.3% | Added |
| Schonfeld Strategic Advisors LLC | 306,034 | $2.02M | 0.02% | +209,034+215.5% | Added |
| Ghost Tree Capital, LLC | 160,898 | $1.06M | 0.36% | −259,433−61.7% | Reduced |
| Sectoral Asset Management Inc | 94,219 | $621.8K | 0.37% | +94,219 | New |
| Two Sigma Investments, LP | 39,621 | $261.5K | 0.00% | +39,621 | New |
| Northern Trust Corp | 34,416 | $227.1K | 0.00% | +34,416 | New |
| Geode Capital Management, LLC | 27,516 | $181.6K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 13,262 | $87.5K | 0.00% | +13,262 | New |
| Morgan Stanley | 8,193 | $54.1K | 0.00% | +8,135+14,025.9% | Added |
| Royal Bank of Canada | 7,915 | $52.0K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 5,574 | $36.8K | 0.00% | +5,574 | New |
| ADAR1 Capital Management, LLC | 1,970 | $13.0K | 0.00% | +1,370+228.3% | Added |
| Wells Fargo & Company | 1,138 | $7.51K | 0.00% | +166+17.1% | Added |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −613,292−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −263,841−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −14,843−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −12,524−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,370−100.0% | Sold out |